CEL-SCI shares are trading higher by 18.6% during Wednesday's session. The company received positive feedback from the FDA regarding their cancer immunotherapy. 9 Out of the Last 10 Summers this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback